Application‑based segmentation isolates four principal use‑cases: acute wounds, chronic wounds, surgical wounds, and burn wounds. Acute wounds—traumatic lacerations, abrasions, and post‑trauma debridement—represent the largest slice at approximately 35 % of market volume, reflecting their high incidence and the need for rapid exudate absorption. Chronic wounds, encompassing diabetic foot ulcers, pressure injuries, and venous leg ulcers, command the greatest share at 40 % due to their prolonged treatment cycles and the premium placed on dressings that maintain a moist environment while minimizing dressing changes. Surgical wounds, including post‑operative incisions and graft sites, contribute around 15 % as surgeons prefer calcium alginate for its hemostatic properties and ease of removal. Burn wounds, although less frequent, account for the remaining 10 % and benefit from the dressing’s ability to manage heavy exudate and reduce infection risk. This application taxonomy directly shapes revenue distribution across the overall market.